OrthoXel™ Evolving Fracture Fixation Announce FDA 510(k) Clearance for new Apex Femoral Nailing System

It is always exciting for us to see the advances of our clients on the global stage. Our firms’ expertise and experience in #MedTech IP work and also that of our own Mark Carmody, gives us the opportunity to work with clients such as OrthoXel Evolving | Fracture | Fixation. OrthoXel recently announced that their new Apex Femoral Nailing System has been granted US FDA 510(k) clearance, following regulatory clearances and first clinical implantations of the Apex Tibial Nailing System earlier this year.

Founded by Pat O’Connor and Charles Daly in 2014, OrthoXel’s business is built on using innovative engineering design to evolve truly next-generation fracture fixation devices.

About the author

Back to Insights